BioCentury
ARTICLE | Clinical News

Atrix starts Phase III

April 18, 2001 7:00 AM UTC

ATRX began a Phase III trial of Atrisone dapsone, an antibiotic and anti-inflammatory sulfone small molecule for the topical treatment of moderate to severe acne. Atrisone incorporates ATRX's SMP tech...